Editorial: Monocyte Heterogeneity and Function

Front Immunol. 2021 Jan 7:11:626725. doi: 10.3389/fimmu.2020.626725. eCollection 2020.

Florent Ginhoux^{1

2

3}, Alexander Mildner⁴, Emmanuel L Gautier⁵, Andreas Schlitzer^{6

7}, Claudia Jakubzick⁸, Chen Varol⁹, Calum Bain¹⁰, Pierre Guermonprez^{11

12}

¹ Singapore Immunology Network (SIgN), ASTAR, Singapore, Singapore.
² Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, the Academia, Singapore, Singapore.
³ Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁴ Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany.
⁵ Sorbonne Université, INSERM UMR-S 1166, Hôpital de la Pitié-Salpêtrière, Paris, France.
⁶ Quantitative Systems Biology, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
⁷ Single Cell Genomics and Epigenomics Unit at the German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.
⁸ Department of Microbiology and Immunology, Dartmouth Geisel School of Medicine, Hanover, NH, United States.
⁹ The Research Center For Digestive Tract and Liver Diseases, Sourasky Medical Center and Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
¹⁰ The University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh BioQuarter, Edinburgh, United Kingdom.
¹¹ King's College London Centre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immmunobiology, London, United Kingdom.
¹² Université de Paris, Centre for Inflammation Research, CNRS ERL8252, INSERM1149, Hopital Bichat, Paris, France.

No abstract available

Keywords: cancer; cardiovascular disease; chronic inflammatory disease; fibrosis; inflammation; inflammation resolution; macrophages; monocytes.

Publication types